GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Sigma-Aldrich Corp (FRA:SIQ) » Definitions » Intrinsic Value: Projected FCF

Sigma-Aldrich (FRA:SIQ) Intrinsic Value: Projected FCF : €58.39 (As of May. 02, 2024)


View and export this data going back to . Start your Free Trial

What is Sigma-Aldrich Intrinsic Value: Projected FCF?

Since the intrinsic value calculations based on Discounted Cash Flow Intrinsic Value: DCF (FCF Based), or Discounted Earnings Intrinsic Value: DCF (Earnings Based) cannot be applied to companies without consistent revenue and earnings, GuruFocus developed a valuation model based on normalized Free Cash Flow and Book Value of the company. The details of how we calculate the intrinsic value of stocks are described in detail here.

As of today (2024-05-02), Sigma-Aldrich's Intrinsic Value: Projected FCF is €58.39. The stock price of Sigma-Aldrich is €130.90. Therefore, Sigma-Aldrich's Price-to-Intrinsic-Value-Projected-FCF of today is 2.2.

The historical rank and industry rank for Sigma-Aldrich's Intrinsic Value: Projected FCF or its related term are showing as below:

FRA:SIQ' s Price-to-Projected-FCF Range Over the Past 10 Years
Min: 0.9   Med: 1.41   Max: 2.94
Current: 2.24

During the past 13 years, the highest Price-to-Intrinsic-Value-Projected-FCF of Sigma-Aldrich was 2.94. The lowest was 0.90. And the median was 1.41.

FRA:SIQ's Price-to-Projected-FCF is not ranked
in the Chemicals industry.
Industry Median: 1.245 vs FRA:SIQ: 2.24

Sigma-Aldrich Intrinsic Value: Projected FCF Historical Data

The historical data trend for Sigma-Aldrich's Intrinsic Value: Projected FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sigma-Aldrich Intrinsic Value: Projected FCF Chart

Sigma-Aldrich Annual Data
Trend Dec05 Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14
Intrinsic Value: Projected FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 35.14 38.83 40.07 41.45 51.66

Sigma-Aldrich Quarterly Data
Dec10 Mar11 Jun11 Sep11 Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15
Intrinsic Value: Projected FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 49.50 51.66 57.38 - -

Competitive Comparison of Sigma-Aldrich's Intrinsic Value: Projected FCF

For the Specialty Chemicals subindustry, Sigma-Aldrich's Price-to-Projected-FCF, along with its competitors' market caps and Price-to-Projected-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sigma-Aldrich's Price-to-Projected-FCF Distribution in the Chemicals Industry

For the Chemicals industry and Basic Materials sector, Sigma-Aldrich's Price-to-Projected-FCF distribution charts can be found below:

* The bar in red indicates where Sigma-Aldrich's Price-to-Projected-FCF falls into.



Sigma-Aldrich Intrinsic Value: Projected FCF Calculation

Since the intrinsic value calculations based on Discounted Cash Flow Intrinsic Value: DCF (FCF Based), or Discounted Earnings Intrinsic Value: DCF (Earnings Based) cannot be applied to companies without consistent revenue and earnings, GuruFocus developed a valuation model based on normalized Free Cash Flow and Book Value of the company.

The details of how we calculate the intrinsic value of stocks are described in detail here.

This method smooths out the free cash flow over the past 6-7 years, multiplies the results by a growth multiple, and adds a portion of Total Stockholders Equity.

Intrinsic Value: Projected FCF = ( Growth Multiple * Free Cash Flow (6 year avg) + 0.8 * Total Stockholders Equity (most recent) ) / Shares Outstanding (Diluted Average)

In the case of negative Total Stockholders Equity, the following formula is used (see Explanation section below for the reason):

Intrinsic Value: Projected FCF = ( Growth Multiple * Free Cash Flow (6 year avg) + Total Stockholders Equity (most recent) / 0.8 ) / Shares Outstanding (Diluted Average)


Add all the Free Cash Flow together and divide 6 will get Sigma-Aldrich's Free Cash Flow(6 year avg) = €365.93.

Sigma-Aldrich's Intrinsic Value: Projected FCF for today is calculated as

Intrinsic Value: Projected FCF=(Growth Multiple*Free Cash Flow (6 year avg)+Total Stockholders Equity (Sep15)*0.8)/Shares Outstanding (Diluted Average)
=(12.018181128481*365.9312+2991.978*0.8)/121.000
=56.13

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sigma-Aldrich  (FRA:SIQ) Intrinsic Value: Projected FCF Explanation

The growth multiple is capped between 8.35 and 17.74.

Total Stockholders Equity weighting is more art than science and it should always be revisited in more detail when researching a company. Weightings from 0% to 100% to more than 100% are possible. 80% was chosen as a happy median after taking the above ideas into consideration.

Sigma-Aldrich's Price-to-Intrinsic-Value-Projected-FCF for today is calculated as

Price-to-Intrinsic-Value-Projected-FCF=Share Price/Intrinsic Value: Projected FCF
=130.90/56.127354067457
=2.33

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sigma-Aldrich Intrinsic Value: Projected FCF Related Terms

Thank you for viewing the detailed overview of Sigma-Aldrich's Intrinsic Value: Projected FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Sigma-Aldrich (FRA:SIQ) Business Description

Industry
Traded in Other Exchanges
N/A
Address
Sigma-Aldrich Corp was incorporated under the laws of the State of Delaware in May 1975. The Company is a life science and a technology company that helps in enhancing human health and safety. The Company manufactures and distributes chemicals, biochemicals and other essential products and equipment products to its customers in research and applied labs as well as in industrial and commercial markets. The Company operates in three units including Research, Applied and SAFC Commercial. The Research unit products and services includes chemicals, reagents and kits, enabling the scientists to discover and develop new drugs and materials; Applied unit products and services includes high quality components and kits, chemical reagents, critical raw materials and certified reference standards, providing customized solutions to and constitute critical components and materials for diagnostic companies, testing laboratories and industrial companies; SAFC Commercial unit's products and services are used by its customers to develop and manufacture pharma, biopharma and electronics products. Its customers include pharmaceutical companies, universities, commercial laboratories, industrial companies, biotechnology companies, non-profit organizations, governmental institutions, diagnostic, chemical and electronics companies and hospitals. The Company's trademarks are the brand names; Sigma-Aldrich, Sigma, Aldrich, Fluka, Riedel-de Haën, Supelco, SAFC, SAFC Biosciences, SAFC Hitech, Genosys, Proligo, Pharmorphix, Cerilliant, Vetec, BioReliance and Cell Marque. The Company is subject to extensive regulation by federal, state and local governments and similar international agencies relating to the manufacture, sale and distribution of its products.

Sigma-Aldrich (FRA:SIQ) Headlines

No Headlines